Ma Q-L, Wang H-J, Shi M-N, An J-H, Ma J, Yu D, Tang M, Shi F-W
Department of Cardiac Surgery, Second Hospital of Hebei Medical University, Shi Jiazhuang, China.
Eur Rev Med Pharmacol Sci. 2016 Oct;20(19):4129-4135.
Coronary heart disease (CHD) is a frequent medical condition in developed countries and is one of the most serious diseases threatening patients' lives. Perioperative myocardial infarction is the major cause of perioperative cardiac death and cardiac arrest, but is difficult to be precisely identified by observing clinical symptoms or assessing cardiac enzyme levels or by ECG examination. Therefore, assessment of patient prognosis requires reliable predictors. In this regard, we tested the prognostic value of serum troponin I (TnI) concentrations.
98 patients undergoing elective simple off-pump coronary artery bypass grafting were recruited. Venous blood samples were collected within 3-5 hours, 18-24 hours, and 36-48 hours post-operation, and associations of TnI concentrations with early outcomes measures (duration of assisted ventilation, length of stay in the ICU, length of postoperative stay, administration of antihypotensive medications, use of intra-aortic balloon pump, and ECG abnormalities) were evaluated. Correlations of postoperative TnI concentrations with the outcomes measures were analyzed by using median TnI concentrations as the cut-off value.
TnI concentrations assessed within 18-24 hours post-operation showed significant associations with most tested outcome measures (p < 0.05 for four out of five comparisons). Furthermore, after building ROC curves, the highest AUC values (> 0.9) were also observed for TnI1 concentrations assessed within this time frame. The optimal cutoff value for TnI concentration was 1.78 ng/ml.
TnI concentrations assessed within 18-24 hours after elective off-pump coronary artery bypass grafting can effectively predict early patient prognosis.
冠心病(CHD)在发达国家是一种常见病症,是威胁患者生命的最严重疾病之一。围手术期心肌梗死是围手术期心脏死亡和心脏骤停的主要原因,但难以通过观察临床症状、评估心肌酶水平或心电图检查来精确识别。因此,评估患者预后需要可靠的预测指标。在这方面,我们测试了血清肌钙蛋白I(TnI)浓度的预后价值。
招募了98例行择期单纯非体外循环冠状动脉搭桥术的患者。在术后3 - 5小时、18 - 24小时和36 - 48小时采集静脉血样本,评估TnI浓度与早期结局指标(辅助通气时间、重症监护病房停留时间、术后住院时间、使用抗低血压药物、使用主动脉内球囊泵以及心电图异常)之间的关联。以TnI浓度中位数作为临界值,分析术后TnI浓度与结局指标的相关性。
术后18 - 24小时评估的TnI浓度与大多数测试的结局指标显著相关(五项比较中有四项p < 0.05)。此外,绘制ROC曲线后,在此时间范围内评估的TnI1浓度也观察到最高的AUC值(> 0.9)。TnI浓度的最佳临界值为1.78 ng/ml。
择期非体外循环冠状动脉搭桥术后18 - 24小时内评估的TnI浓度可有效预测患者早期预后。